{
    "root": "aff50a15-df39-495f-a145-0ba59660eed8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": "gabapentin",
    "value": "20250523",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        },
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3311"
        },
        {
            "name": "CALCIUM SULFATE DIHYDRATE",
            "code": "4846Q921YM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32583"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13038"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "2165RE0K14"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        }
    ],
    "indications": {
        "text": "gabapentin indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1,800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 mg/kg/day 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 mg/kg/day 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gabapentin capsules , usp supplied follows : 100 mg capsules : white hard gelatin capsules printed \u201c 137 \u201d cap body ; available : bottles 100 : child resistant cap -ndc 62756-137-02 non child resistant cap -ndc 62756-137-03 bottles 500 : non child resistant cap - ndc 62756-137-05 bottles 1000 : non child resistant cap - ndc 62756-137-04 unit dose 50 's : -ndc 62756-137-01 300 mg capsules : yellow hard gelatin capsules printed \u201c 138 \u201d cap body ; available : bottles 100 : child resistant cap -ndc 62756-138-02 non child resistant cap -ndc 62756-138-03 bottles 500 : non child resistant cap - ndc 62756-138-05 bottles 1000 : non child resistant cap - ndc 62756-138-04 unit dose 50 's : -ndc 62756-138-01 400 mg capsules : orange hard gelatin capsules printed \u201c 139 \u201d cap body ; available : bottles 100 : child resistant cap -ndc 62756-139-02 non child resistant cap -ndc 62756-139-03 bottles 500 : non child resistant cap -ndc 62756-139-05 bottles 1000 : non child resistant cap -ndc 62756-139-04 unit dose 50 's : -ndc 62756-139-01 gabapentin tablets , usp supplied follows : 600 mg tablets : white white , biconvex , oval shaped , film-coated tablet scored sides debossed \u201c 202 \u201d one side ( \u201c 2 \u201d one side score line \u201c 02 \u201d side score line ) , available : bottles 100 : child resistant cap -ndc 62756-202-01 bottles 500 : non child resistant cap- ndc 62756-202-03 800 mg tablets ; white white , biconvex , oval shaped , film-coated tablet scored sides debossed \u201c 204 \u201d one side ( \u201c 2 \u201d one side score line \u201c 04 \u201d side score line ) , available : bottles 100 : child resistant cap - ndc 62756-204-01 bottles 500 : non child resistant cap - ndc 62756-204-03 storage store 20\u00b0 25\u00b0c ( 68 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin is indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "Postherpetic Neuralgia ( 2.1 ) Dose can be titrated up as needed to a dose of 1,800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 mg/kg/day\u00a0to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 mg/kg/day to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "Gabapentin capsules, USP are supplied as follows:\n                  100 mg capsules:\n                  White hard gelatin capsules printed with \u201c137\u201d on cap and body; available in:\n                  Bottles of 100:\u00a0\u00a0\u00a0 Child Resistant Cap ------------------------------------------NDC 62756-137-02\n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Non Child Resistant Cap -----------------------------------NDC 62756-137-03\n                  Bottles of 500:\u00a0\u00a0\u00a0 Non Child Resistant Cap ------------------------------------ NDC 62756-137-05\n                  Bottles of 1000:\u00a0 Non Child Resistant Cap ------------------------------------ NDC 62756-137-04\n                  Unit dose 50's: ------------------------------------------------------------------NDC 62756-137-01\n                  \n                  300 mg capsules:\n                  Yellow hard gelatin capsules printed with \u201c138\u201d on cap and body; available in:\n                  Bottles of 100:\u00a0\u00a0\u00a0 Child Resistant Cap ------------------------------------------NDC 62756-138-02\n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Non Child Resistant Cap ----------------------------------NDC 62756-138-03\n                  Bottles of 500:\u00a0\u00a0\u00a0 Non Child Resistant Cap ------------------------------------ NDC 62756-138-05\n                  Bottles of 1000:\u00a0 Non Child Resistant Cap ------------------------------------ NDC 62756-138-04\n                  Unit dose 50's: ------------------------------------------------------------------NDC 62756-138-01\n                  \n                  400 mg capsules:\n                  Orange hard gelatin capsules printed with \u201c139\u201d on cap and body; available in:\n                  Bottles of 100:\u00a0\u00a0\u00a0 Child Resistant Cap -----------------------------------------NDC 62756-139-02\n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Non Child Resistant Cap ----------------------------------NDC 62756-139-03\n                  Bottles of 500:\u00a0\u00a0\u00a0 Non Child Resistant Cap ------------------------------------NDC 62756-139-05\n                  Bottles of 1000:\u00a0 Non Child Resistant Cap ------------------------------------NDC 62756-139-04\n                  Unit dose 50's: -----------------------------------------------------------------NDC 62756-139-01\n                  Gabapentin tablets, USP are supplied as follows:\n                  600 mg tablets:\n                  White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with \u201c202\u201d on one side (\u201c2\u201d on one side of score line and \u201c02\u201d on other side of score line), available in:\n                  Bottles of 100:\u00a0\u00a0\u00a0 Child Resistant Cap -----------------------------------------NDC 62756-202-01\n                  Bottles of 500:\u00a0\u00a0\u00a0 Non Child Resistant Cap------------------------------------ NDC 62756-202-03\n                  \n                  800 mg tablets;\n                  White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with \u201c204\u201d on one side (\u201c2\u201d on one side of score line and \u201c04\u201d on other side of score line), available in:\n                  Bottles of 100:\u00a0\u00a0\u00a0 Child Resistant Cap ------------------------------------------ NDC 62756-204-01\n                  Bottles of 500:\u00a0\u00a0\u00a0 Non Child Resistant Cap ------------------------------------ NDC 62756-204-03\n                  \n                  \n                     Storage\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68 to 77\u00b0F); excursions permitted between 15\u00b0 and 30\u00b0C (59\u00b0 and 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "gabapentin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}